Anett Perlberg

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Lexicon Pharmaceuticals, Inc., Novartis Ag, Rspr Pharma Ab. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anett Perlberg. Retrieved from https://idiyas.com/inventor/anett-perlberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 71.4

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

4 out of 89

Lexicon Pharmaceuticals, Inc.

Years Active: 2012-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9174985 - Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists (2015-11-03),

2. 9067962 - Methods of treating diabetes (2015-06-30),

3. 9006431 - Crystalline form of pemirolast (2015-04-14),

4. 8809340 - Crystalline form (2014-08-19),

5. 8653094 - Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use (2014-02-18),

6. 8217156 - Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use (2012-07-10),

7. 8193204 - Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use (2012-06-05),

Title: Anett Perlberg: Transforming Technological and Sustainable Landscapes

Introduction:

Anett Perlberg, a visionary inventor hailing from Gunzgen, CH, is renowned for his unwavering commitment to innovation that positively impacts the world. With seven patents under his belt, Perlberg has carved a niche for himself in the realms of technology and sustainability.

Latest Patents:

Perlberg's recent patents include revolutionary discoveries such as "Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists," showcasing his dedication to advancing healthcare through novel pharmaceutical compositions. Additionally, his work on "Methods of treating diabetes" exhibits his drive to address pressing global health challenges.

Career Highlights:

Having contributed his expertise to esteemed companies such as Lexicon Pharmaceuticals, Inc. and Novartis AG, Perlberg has demonstrated his prowess in translating innovative ideas into tangible solutions. His strategic approach to research and development has yielded groundbreaking patents that hold promise for the future of medicine and sustainability.

Collaborations:

In his professional journey, Perlberg has collaborated with accomplished individuals like Susan Margaret De Paul and Matthew Mangzhu Zhao. Together, they have synergized their skills and expertise to push the boundaries of technological innovation and pave the way for a more sustainable future.

Conclusion:

Anett Perlberg's legacy as a pioneering inventor is solidified by his passion for innovation and his relentless pursuit of making a positive impact on society. Through his patents and collaborations, Perlberg continues to inspire change and drive progress in the fields of technology and sustainability, leaving an indelible mark on the world.

Profile summary based on public USPTO records.